135
Participants
Start Date
January 31, 2013
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Buprenorphine
Study participants will be randomly assigned 1:1 to buprenorphine (experimental/intervention) or methadone (active comparator). We will stratify by HIV status to ensure an equal number of HIV-infected participants in each group.
Methadone
Study participants will be randomly assigned 1:1 to buprenorphine (experimental/intervention) or methadone (active comparator). We will stratify by HIV status to ensure an equal number of HIV-infected participants in each group.
Fordham University, The Bronx
Albert Einstein College of Medicine of Yeshiva University, The Bronx
National Institute on Drug Abuse (NIDA)
NIH
Montefiore Medical Center
OTHER
Fordham University
OTHER
Albert Einstein College of Medicine
OTHER